Free Trial

Oppenheimer's Rating of Amrize on 9/9/2025

On September 9, 2025, Oppenheimer updated its outlook on Amrize (NYSE:AMRZ) with the action "Initiated Coverage", setting a "Outperform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Oppenheimer Holdings, Inc.

DateCompanyAction
9/24/2025
Integral Ad Science Holding Corp. stock logo
IAS
Integral Ad Science
Downgrade
9/23/2025
Citigroup Inc. stock logo
C
Citigroup
Lower Price Target
9/23/2025
AppLovin Corporation stock logo
APP
AppLovin
Boost Price Target
9/23/2025
U.S. Bancorp stock logo
USB
U.S. Bancorp
Lower Price Target
9/23/2025
The PNC Financial Services Group, Inc stock logo
PNC
The PNC Financial Services Group
Lower Price Target
9/23/2025
Bank of America Corporation stock logo
BAC
Bank of America
Lower Price Target
More Ratings From Oppenheimer Holdings, Inc.